EUVIMEDEUVIMED entdecken
Crossref

17,18-Epoxyeicosatetraenoic acid and its metabolite attenuate interleukin-33–induced airway inflammation involving Group 2 innate lymphoid cells

Ichiro Tojima iD, Tatsuji Nishiguchi, Kento Kawakita, Yoshihito Kubo, Takuya Murao, Keigo Nakamura, Koji Matsumoto, Hideaki Kouzaki, Shino Shimizu, Takeshi Shimizu, Yukinori Takenaka

International Immunology · 31.10.2026 · 38 (11) · 704-715

DOI: 10.1093/intimm/dxag029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, online erschienen am 03.06.2026. Verfasst von Ichiro Tojima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Shiga University of Medical Science, Otsu, Japan. Hauptthemen laut MEDLINE: Lymphocytes, Interleukin-33, Arachidonic Acids, Immunity, Innate. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Group 2 innate lymphoid cells (ILC2s) play critical roles in Type 2 airway inflammation. 17,18-Epoxyeicosatetraenoic acid (17,18-EpETE), an eicosapentaenoic acid metabolite, is generated from dietary omega-3 fatty acids and may have anti-inflammatory activities. We evaluated the effect of 17,18-EpETE and its metabolite, 17,18-dihydroxy-eicosa-5,8,11,14-tetraenoic acid (17,18-diHETE), on interleukin (IL)-33–induced airway inflammation involving ILC2s. We evaluated the in vitro effects of 17,18-EpETE and 17,18-diHETE on the IL-33–induced production of IL-5 and IL-13 by human ILC2s (isolated from peripheral blood) using enzyme-linked immunosorbent assay. Expression of the corresponding fatty acid receptors and the GATA-binding protein 3 (GATA-3) transcription factor were examined using flow cytometry and quantitative real-time polymerase chain reaction. Additionally, we examined the in vivo effects of 17,18-EpETE or 17,18-diHETE in a mouse model of Type 2 airway inflammation induced by intranasal instillation of IL-33. 17,18-EpETE or 17,18-diHETE inhibited IL-33–induced production of IL-5 and IL-13, and IL-33–induced expression of GATA-3 in human ILC2s. GW1100, an antagonist of G protein-coupled receptor 40, or GW9662, an antagonist of peroxisome proliferator-activated receptor γ, counteracted the inhibitory effects of 17,18-EpETE or 17,18-diHETE on the IL-33–induced production of IL-5 and IL-13 by ILC2s. Intranasal administration of 17,18-EpETE or 17,18-diHETE attenuated IL-33–induced eosinophil infiltration and mucus production in mouse nasal mucosa, and the production of IL-5 and IL-13 in lung tissue and bronchoalveolar lavage fluid. The present study demonstrated the anti-inflammatory effects of 17,18-EpETE and 17,18-diHETE on IL-33–induced airway inflammation involving ILC2s. Intranasal administration of 17,18-EpETE may be a new therapeutic approach for the treatment of intractable Type 2 airway inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphocytesInterleukin-33Arachidonic AcidsImmunity, InnateAsthmaInflammationEicosapentaenoic AcidHumansAnimalsMiceInterleukin-5Mice, Inbred BALB CGATA3 Transcription Factor

Stichwörter der Autor:innen

17,18-EpETE17,18-diHETEeicosapentaenoic acideosinophilmucin

Substanzen

17,18-epoxy-5,8,11,14-eicosatetraenoic acidInterleukin-33Arachidonic AcidsInterleukin-5GATA3 Transcription FactorEicosapentaenoic Acid

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Shiga University of Medical Science, Otsu, Japan.

ORCID-Profile: Ichiro Tojima

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Tojima, I., Nishiguchi, T., Kawakita, K., Kubo, Y., Murao, T., Nakamura, K., Matsumoto, K., Kouzaki, H., Shimizu, S., Shimizu, T., & Takenaka, Y. (2026). 17,18-Epoxyeicosatetraenoic acid and its metabolite attenuate interleukin-33–induced airway inflammation involving Group 2 innate lymphoid cells. International Immunology, 38(11), 704-715. https://doi.org/10.1093/intimm/dxag029

Vancouver

Tojima I, Nishiguchi T, Kawakita K, Kubo Y, Murao T, Nakamura K, et al. 17,18-Epoxyeicosatetraenoic acid and its metabolite attenuate interleukin-33–induced airway inflammation involving Group 2 innate lymphoid cells. International Immunology. 2026;38(11):704-715. doi:10.1093/intimm/dxag029

BibTeX
@article{Tojima2026,
  author = {Tojima, Ichiro and Nishiguchi, Tatsuji and Kawakita, Kento and Kubo, Yoshihito and Murao, Takuya and Nakamura, Keigo and Matsumoto, Koji and Kouzaki, Hideaki and Shimizu, Shino and Shimizu, Takeshi and Takenaka, Yukinori},
  title = {17,18-Epoxyeicosatetraenoic acid and its metabolite attenuate interleukin-33–induced airway inflammation involving Group 2 innate lymphoid cells},
  journal = {International Immunology},
  year = {2026},
  volume = {38},
  number = {11},
  pages = {704--715},
  doi = {10.1093/intimm/dxag029}
}
Kostenlos starten →